Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway
- PMID: 31079003
- DOI: 10.1016/j.biopha.2019.108939
Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway
Abstract
Family with sequence similarity 83 member B (FAM83B) has been recently identified as an oncogene involved in the development of various human cancers. However, the role of FAM83B in endometrial cancer tumorigenesis and metastasis is unclear. In this study, we found that the expression of FAM83B was upregulated in endometrial cancer tissues and cell lines. FAM83B expression in endometrial cancer tissues was significantly higher than that in normal tissues and higher FAM83B expression was closely related to poorly survival rate according to TCGA analysis. Moreover, FAM83B expression was correlated with International Federation of Gynecology and Obstetrics (FIGO)stage and myometrial invasion but had no significant correlation with age or histological grade. FAM83B knockdown inhibited endometrial cancer cell proliferation, migration, and invasion arrested the cell cycle at the G1/S stage and promoted apoptosis. FAM83B knockdown also inhibited endometrial cancer growth and lung metastasis in vivo. FAM83B knockdown silenced the PI3K/AKT/mTOR pathway and promoted autophagy. Furthermore, activation of the PI3K/AKT/mTOR pathway reversed FAM83B knockdown-induced autophagy promotion and inhibition of proliferation, migration, and invasion in endometrial cancer cells. Taken together, these results indicate that FAM83B promotes endometrial cancer cell proliferation and metastasis by inhibiting autophagy via activating the PI3K/AKT/mTOR pathway.
Keywords: Autophagy; Endometrial cancer; FAM83B; Neoplasm Metastasis; PI3K/Akt signalling.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
Similar articles
-
FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.Oncotarget. 2013 May;4(5):729-38. doi: 10.18632/oncotarget.1027. Oncotarget. 2013. PMID: 23676467 Free PMC article.
-
MicroRNA‑199a/b‑5p inhibits endometrial cancer cell metastasis and invasion by targeting FAM83B in the epithelial‑to‑mesenchymal transition signaling pathway.Mol Med Rep. 2021 May;23(5):304. doi: 10.3892/mmr.2021.11943. Epub 2021 Mar 2. Mol Med Rep. 2021. PMID: 33649801 Free PMC article.
-
Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.Gene. 2019 May 25;698:50-60. doi: 10.1016/j.gene.2019.02.044. Epub 2019 Feb 27. Gene. 2019. PMID: 30822475
-
Activation of PI3K/Akt/mTOR pathway and dual inhibitors of PI3K and mTOR in endometrial cancer.Curr Med Chem. 2014;21(26):3070-80. doi: 10.2174/0929867321666140414095605. Curr Med Chem. 2014. PMID: 24735369 Review.
-
The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer.Clin Cancer Res. 2012 Nov 1;18(21):5856-64. doi: 10.1158/1078-0432.CCR-12-0662. Epub 2012 Oct 18. Clin Cancer Res. 2012. PMID: 23082003 Review.
Cited by
-
Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review.J Cancer. 2023 Jun 26;14(10):1888-1903. doi: 10.7150/jca.83420. eCollection 2023. J Cancer. 2023. PMID: 37476189 Free PMC article. Review.
-
Green Tea in Reproductive Cancers: Could Treatment Be as Simple?Cancers (Basel). 2023 Jan 30;15(3):862. doi: 10.3390/cancers15030862. Cancers (Basel). 2023. PMID: 36765820 Free PMC article. Review.
-
FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.BMC Pulm Med. 2023 Jan 23;23(1):32. doi: 10.1186/s12890-022-02303-5. BMC Pulm Med. 2023. PMID: 36690987 Free PMC article.
-
Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma.Cancers (Basel). 2022 Dec 15;14(24):6210. doi: 10.3390/cancers14246210. Cancers (Basel). 2022. PMID: 36551694 Free PMC article. Review.
-
An eleven autophagy-related genes-based prognostic signature for endometrial carcinoma.J Egypt Natl Canc Inst. 2022 Oct 10;34(1):42. doi: 10.1186/s43046-022-00135-2. J Egypt Natl Canc Inst. 2022. PMID: 36210389
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
